Singapore markets closed
  • Straits Times Index

    3,287.95
    +5.98 (+0.18%)
     
  • S&P 500

    4,662.85
    +3.82 (+0.08%)
     
  • Dow

    35,911.81
    -201.79 (-0.56%)
     
  • Nasdaq

    14,893.75
    +86.95 (+0.59%)
     
  • BTC-USD

    42,629.61
    -598.35 (-1.38%)
     
  • CMC Crypto 200

    1,023.02
    -2.71 (-0.26%)
     
  • FTSE 100

    7,610.04
    +67.09 (+0.89%)
     
  • Gold

    1,819.20
    +2.70 (+0.15%)
     
  • Crude Oil

    83.85
    +0.03 (+0.04%)
     
  • 10-Yr Bond

    1.7720
    +0.0610 (+3.57%)
     
  • Nikkei

    28,333.52
    +209.24 (+0.74%)
     
  • Hang Seng

    24,218.03
    -165.29 (-0.68%)
     
  • FTSE Bursa Malaysia

    1,542.92
    -12.41 (-0.80%)
     
  • Jakarta Composite Index

    6,645.05
    -48.35 (-0.72%)
     
  • PSE Index

    7,223.83
    -37.51 (-0.52%)
     

Global Congestive Heart Failure Clinical Trial Pipeline Market Report 2021 - ResearchAndMarkets.com

·2-min read

DUBLIN, December 02, 2021--(BUSINESS WIRE)--The "Global Congestive Heart Failure Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

Congestive Heart Failure Pipeline Highlights 2021 provides the most up-to-date information on key pipeline products in the global Congestive Heart Failure market.

It covers emerging therapies for Congestive Heart Failure in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Congestive Heart Failure pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Congestive Heart Failure pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Congestive Heart Failure pipeline products by the company.

Short-term Launch Highlights:

Find out which Congestive Heart Failure pipeline products will be launched in the US and Ex-US till 2025.

Summary

  • Congestive Heart Failure phase 3 clinical trial pipeline products

  • Congestive Heart Failure phase 2 clinical trial pipeline products

  • Congestive Heart Failure phase 1 clinical trial pipeline products

  • Congestive Heart Failure preclinical research pipeline products

  • Congestive Heart Failure discovery stage pipeline products

  • Congestive Heart Failure pipeline products short-term launch highlights

Countries Covered

  • Global

  • Europe

  • US

  • Germany

  • France

  • UK

  • Spain

  • Italy

  • Japan

For more information about this report visit https://www.researchandmarkets.com/r/m3ja8x

View source version on businesswire.com: https://www.businesswire.com/news/home/20211202005692/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting